3P India Equity Fund trimmed its stake in Wockhardt Limited from 1.65% to 1.15%, selling 8,25,705 shares worth ₹156.95 Cr at ₹1900.70 apiece.
A global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals, and topicals for diverse therapeutic applications. Wockhardt operates across multiple segments, serving domestic and international markets with a comprehensive product portfolio spanning conventional pharmaceuticals and advanced biopharmaceutical solutions. The company distinguishes itself through vertically integrated operations and a focus on both established and emerging therapeutic areas.
Launched May 2023 by 3P Investment Managers, managing around Rs 16,269 cr by January 2026, making it one of the fastest-scaling India equity AIFs ever. Managed by Prashant Jain, who ran HDFC Mutual Fund as CIO for 18 years (2004 to 2022) and is among India's most-followed long-only managers. Mohnish Pabrai is an anchor investor.